Received a response from Rebecca , The Team are Highly Encouraged by the recent Complete Response adding further to compelling data.
The Current SP is confusing but that's the market.
I have highlighted to her that the early broadcast of a CR and then dragging of the chain for months has seen the SP decline 50% + ,whilst this lengthy drawn out CR is one of the worst I have seen in 20 years...
My thoughts are still "we had a funder" and either they stalled for better "stronger" data or they just wanted to delay and the uncertainty would negatively affect the SP ,,as it has done.
The irony with CHM is " as the Science has progressed and venture risk has been reduced there has been NO corresponding increase in the SP , in fact the exact opposite has occurred for years, I can really feel for those that were part of the IPO"
- Forums
- ASX - By Stock
- Ann: 2024 Annual Report update
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

Received a response from Rebecca , The Team are Highly...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $69.79K | 17.44M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 26298938 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 9548289 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
40 | 26298938 | 0.003 |
16 | 13800507 | 0.002 |
10 | 50600000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 9548289 | 12 |
0.005 | 14771167 | 22 |
0.006 | 13747410 | 16 |
0.007 | 4700000 | 4 |
0.008 | 8542434 | 6 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online